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digital treatments and considered cost-effectiveness to be the primary incentive for integration into care services.
Low feasibility of delivery within existing care serviceswas considered to be a primary barrier. Digital treatments
were regardedmore suitable for milder forms of depression. Stakeholders showed greater acceptability towards
blended treatment (the integration of face-to-face and internet sessions within the same treatment protocol)
compared to standalone internet treatments. Organisations in countries with developed e-health solutions re-
ported greater knowledge and acceptability of digital treatments.
Conclusion: Mental health stakeholders in Europe are aware of the potential beneﬁts of digital interventions.
However, there are variations between countries and stakeholders in terms of level of knowledge about such in-
terventions and their feasibility within routine care services. The high acceptance of blended treatments is an in-
teresting ﬁnding that indicates a gradual integration of technology into clinical practicemay ﬁt the attitudes and
needs of stakeholders. The potential of the blended treatment approach, in terms of enhancing acceptance of dig-
ital treatment while retaining the beneﬁt of cost-effectiveness in delivery, should be further explored.
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Depression is currently a leading cause of years lived with disability
(YLD) in 146 countries (Vos et al., 2015) andMajor Depressive Disorder
is expected to become the greatest contributor to the global burden of
disease (WHO, 2008). Treatment resources are insufﬁcient and it is an
international priority to increase the coverage of interventions for de-
pression (WHO, 2013).
Experts emphasize that the digital technology has the potential to im-
prove access to care for mental disorders (Andersson, 2016). Digital psy-
chological interventions are under development and testing in Australia
(Perini et al., 2009), Canada (Hadjistavropoulos et al., 2016), The United
States (Andersson, 2016; Mohr et al., 2013) and a range of European
countries (Andersson et al., 2005; Berger et al., 2011; Buntrock et al.,
2016; O'Mahen et al., 2014; Ruwaard et al., 2009). The digital treatment
approach involves adapting standard face-to-face protocols into
computerised self-helpmaterial that is delivered over a set timeperiod ei-
ther as pure self-help programor alongside brief therapist support. In this
way the treatments become highly automated and geographically inde-
pendent, which positively impact therapist capacity and patient access.
Currently, digital programs that are based on Cognitive Behavioural Ther-
apy (internet-based CBT or ICBT) have been evaluated in N100 controlled
trials with promising results for several mental and somatic disorders
(Andersson, 2016). The reported clinical effects for therapist-supported
ICBT for depression are large and stable over a number of trials
(Cuijpers et al., 2015). In direct comparison to face-to-face treatment ef-
fect sizes are similar (Andersson et al., 2014; Andersson et al., 2016). A rel-
atively newly developed but increasingly applied route in the ﬁeld of
digital treatment is ‘blended treatment’ (BT) (Wentzel et al., 2016). In
this approach self-helpmaterial is blendedwith face-to-face sessions (re-
duced in number compared to standard treatment) (Kleiboer et al., 2016).
The blended treatment emphasises the integration of standard anddigita-
lizedmodalities and the advantages this brings for both the therapist and
thepatient. Face-to-face sessions enablemore extensive therapist support
and improved monitoring of the patient's wellbeing in comparison to
standalone ICBT. As the standardized parts of treatment are delivered on-
line it alsomeans that sessions can be used to address and tailor the treat-
ment to individual patient's needs. The standardized components can be
delivered online, which for the patient means unlimited access to treat-
ment and less demands in terms of travel and costs (Romijn et al.,
2015). It has been suggested that BT can be an alternative to ICBT (the
most common treatment for mild to moderate depression), for example
in specialized treatment services and for patientswithmore severe symp-
tomatology (Kleiboer et al., 2016). Examples of BT designs that have been
evaluated with promising result are unguided self-help reading material
combined with face-to-face sessions, and digital therapy as a partial re-
placement of face-to-face sessions (Ly et al., 2015; Wentzel et al., 2016).
In some countries like Australia, Canada and Sweden there are ex-
amples of ICBT programmes being transferred from research settings
into utilisation within regular care services (Andersson and Hedman,
2013; Hadjistavropoulos et al., 2014; Titov et al., 2016). An integration
of ICBT treatment into national health services is now on the agenda
in the European Union (Vis et al., 2015). This is reﬂected in several on-
going European research and funding programs (E-COMPARED, Joint
action and Wellbeing, Horizon 2020). Effectiveness-research to estab-
lish clinical and cost-beneﬁts of ICBT in realworld settings has been con-
ducted (e.g. Hadjistavropoulos et al., 2014; Hedman et al., 2014;
Ruwaard et al., 2012; Titov et al., 2016) and is currently researched in
different European settings (Kemmeren et al., 2016; Kleiboer et al.,
2016). Therefore, it is of importance to assess the views of all stake-
holders that would be directly involved or affected by the implementa-
tion of ICBT treatments such as government bodies, care providers,
professionals, patients and funders. Limited research exists that investi-
gates current knowledge, attitudes and expectations of digital treat-
ment. This survey was conducted with the aim to explore European
mental health care stakeholders' knowledge and acceptance of ICBTand BT, and their expectations when considering integration of digital
treatments into regular care services. The survey was conducted in the
context of the wider research project E-COMPARED, that was initiated
to provide mental healthcare stakeholders with evidence-based infor-
mation about the clinical and cost-effectiveness of digital treatments
for depressive disorders.
2. Material and methods
2.1. Background
This studypresentsﬁndings on European stakeholders' self-reported
knowledge and attitudes towards ICBT and BT in treatment of adult de-
pression. The results derive from a European online survey that was
conducted by the E-COMPARED project between March to June 2014.
Six survey items that assessed stakeholders' views on ICBT and BT
were selected to be discussed in this paper. The original survey was
more comprehensive and also assessed views on standard pharmaco-
logical and therapeutic treatments for adult depression. The survey in
its full length can be found in Appendix 2.
2.2. Survey development and design
No prior surveys existed on stakeholder's views on standard treat-
ments and digital treatments for depression, therefore this survey was
conducted by the E-COMPARED consortium. Initially the consortium
jointly developed an English version of the survey, thereafter consor-
tium members translated the survey into their ﬁrst languages (French,
German, Dutch, Polish, Spanish, Swedish). Consortium members that
adapted the survey were involved in the development of the original
version and the process did not include formal back-translation.
The full survey was comprised of 40 questions that assessed views
on standard treatments and novel digital treatments (ICBT and BT) on
adult depression. The survey covered four thematic areas: i) knowledge
of treatments, ii) attitudes towards treatments, iii) acceptability (rec-
ommendation) of treatments and iiii) near future expectations of treat-
ments. The survey questions were presented in the form of six-point
scales (0–5), yes/no options and as ranking alternatives. Beyond stan-
dard response options the survey allowed free text comments and the
alternative “not applicable”. ICBT and BTwere not expected to be famil-
iar to respondents and these treatments were presented in explanatory
terms. Table 1 shows how the treatment concept and survey questions
on ICBT and BT were presented to participants. See Appendix 1 for orig-
inal survey items. The aim was to optimise understanding (attributing
the samemeaning to the terms) and the validity of the outcome. Partic-
ipants were asked ﬁll out the survey on behalf of their organisation and
to contribute opinions on digital treatment regardless if these treat-
ments were currently accessible in their country.
2.3. Included countries
The surveywas conducted in France, Germany, Netherlands, Poland,
Spain, Sweden, Switzerland and The United Kingdom. The selection of
countries was made a priori to the survey on the basis of the constella-
tion of the E-COMPARED consortium, which in turn was composed to
reﬂect the diversity in Europe in terms of health care infrastructure
and level of e-mental health implementation. A distinction of participat-
ing countries (as ‘frontrunners’, ‘learners’ and ‘followers’) was made a
priori to the survey. The Netherlands, Sweden, and the United Kingdom
(UK) has in relation to other European countries come far in terms of in-
clusion of e-health and presence of digital treatment approaches, there-
fore these countries were considered ‘frontrunners’ in the ﬁeld. In
Germany, Spain and Switzerland, health technologies are currently
evolving and these countries were categorized as ‘follower’ countries.
In France and Poland the current experience and practice of e-health
is limited, and these countries were considered ‘learner’ countries.
Table 1
Overview of analysed survey items.
Survey theme Presented item Item design
Knowledge of
treatments
(ICBT)
“To what extent does your organisation have knowledge about internet-based psychotherapy
(referred to as online therapy and web-based treatment) as a treatment tool for adult
depression?”
Six-point scale: 0 = no knowledge at all, to 5 = very
good knowledge Opt out option “does not apply”
Attitude towards
treatments (ICBT)
“Is your organisation discussing and/or proclaiming internet-based psychotherapy as a future
enhancement in mental health care?”
Single-choice question: “yes”, “partly”, “no”, “does not
apply”.
Acceptance of
treatments
(ICBT, BT)
“Do you/Would your organisation recommend: 1) stand-alone treatment full psychotherapy
program for computer/tablet/smartphone, with online educational material and communication
with health care professional?” (ICBT)
2) “Traditional face-to-face treatment with the addition of a web-based platform and digital
tools for support, with the aim of reducing the number of face-to-face sessions while
maintaining the same treatment quality” (BT)
Single-choice question: “yes”, “no”, “does not apply”.
Expectations of
treatments
(ICBT)
“What does your organisation expect to be the most important incentive/barrier for integrating
internet-based psychotherapy as a stand-alone treatment for adult depression in your country's
health care system?”
Choose alternative from presented list.
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The aim was to identify organisations (stakeholders) that were in-
volved in the delivery of depression treatment to the adult population.
In order to identify relevant stakeholders, consortium members com-
piled a list of organisations that were active in the ﬁeld of mental health
care and the organisation categories that were present in all participat-
ing countries were chosen as stakeholders to target for the survey. The
selected stakeholder groups were i) government bodies ii) care pro-
viders and professionals, iii) researchers at universities and institutes,
iv) service funders, v) technology developers/providers of digital ser-
vices within mental health, and vi) organisations representing pa-
tients/users. A description and overview of targeted stakeholder
categories is presented in Fig. 1.
2.5. Recruitment to the survey
Consortiumpartners recruited stakeholders in their respective coun-
try. The recruitment guideline was to recruit at least 1–3 organisations
from each stakeholder category. No higher limit was set. Based on the
stakeholder categories, consortium members identiﬁed organisations
and invited their representatives to participate in the survey via email.
The email brieﬂy presented the E-COMPARED project and the requestFig. 1. Targeted stakto participate in the survey. It contained a link that directed to the online
survey. On the survey start-page the individual was instructed to pro-
vide name and organisation, and to answer the survey on the behalf of
the organisation (and not as an individual agent). Fig. 2 illustrates the
start-page as presented to participants in the survey.
3. Analysis
Five survey items that assessed stakeholder's views on ICBT and BT
were selected for this paper. The survey data was analysed by using de-
scriptive statistics, Kruskal-Wallis tests, χ2 and analysis of variance
(ANOVA). Post-hoc tests were used to test differences in responses be-
tween stakeholder categories and countries (frontrunner countries versus
other countries, Germany versus other countries). The completion rate
varied between items, therefore, sample sizes are continuously presented.
4. Results
4.1. Enrolment
In total 764 organisations was contacted and 175 returned the ques-
tionnaire, corresponding to a 23% response-rate. The number of targeted
organisations and response rates varied between countries (Poland 29/eholder groups.
Fig. 2. Information on the E-COMPARED survey start page.
4 N. Topooco et al. / Internet Interventions 8 (2017) 1–9300, United Kingdom 4/24, France 4/28, Germany 58/232, Switzerland
13/49, Netherlands 22/77, Sweden 23/31, Spain 22/23), see Fig. 3 for re-
sponse-rates. The participating stakeholders represented all countries
and included 88 organisations in the category of providers and profes-
sionals, 27 government bodies, 26 research institutions (e.g. universities
and institutes), 14 organisations that represented patients/service-users,
11 organisations within service funding and 9 organisations that repre-
sented technology provider/developers. On subgroup level Germany
had most responders (33% of the total sample) and the most well repre-
sented stakeholder group was care providers/professionals (50% of the
total sample). See Table 2 for distributions on country and stakeholder
level. Respondentswere evenly distributed between associations operat-
ing on national (38%), regional (34%) and local (28%) level.
4.2. Knowledge
Stakeholders' self-reported knowledge of internet-based treatment
for depression is presented in Table 3. Organisationswere asked to indi-
cate their knowledge of any kind of internet-based psychological treat-
ment even if not currently accessible in their country. Respondents self-reported their knowledge of digital treatment (ICBT) on a six-point
scale (0–5). The total sample reported a moderate level of knowledge
(M = 2.7). There were differences between stakeholder categories,
with technology developers reporting higher level of knowledge
(M = 4.3) compared to government bodies (M = 1.8) and care pro-
viders (M= 2.6) (Tukey p b 0.027–0.001).4.3. Activity
Stakeholders' activity on the topic of digital treatments for depres-
sion (ICBT) is reported in Table 4. Respondents were asked to indicate
whether their organisation in some way discussed or promoted digital
treatment for depression, and they replied by selecting “yes”, “partly”
or “no”. Considering the whole sample, the majority of organisations
(64%) reported that their organisation to some extent discussed or sup-
ported digital treatment. There were differences between stakeholder
categories (Kruskal-Wallis test, p b 0.001), characterised by lower activ-
ity among government bodies compared to care providers, researchers
and technology providers.
1
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r
percentage of the total sample
esponse-rate
Fig. 3. Response rates and percentage of the total sample for participating countries.
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Stakeholders' acceptance of ICBT and BT respectively is presented in
Table 5. Organisations were asked to indicate whether in their opinion,
ICBT andBT couldbe recommended for the treatment of adult depression.
They replied by indicating “yes”, “no”, or “not applicable”. In the total
sample nearly half of respondents (47%) recommended standalone ICBT
formild depression. Formoderate and severe depression, the recommen-
dation-rates were 16% and 2% respectively. BT was recommended by the
majority of stakeholders for mild (70%) and moderate (57%) depression
andby 27% for severe depression. Therewere differences between groups
for both ICBT andBT, characterised by government bodies recommending
treatments to a lower degree than patient/service-users, caregivers and
research institutions (Kruskal-Wallis, p b 0.05–0.002). To further explore
the difference in acceptance for ICBT and BT, free text comments made
throughout the survey were assessed (also for items not discussed in
this paper). No commentsweremade onBT. Commentsmade onpossible
disadvantages on ICBT (n = 52) most frequently highlighted concerns
about clinical effect and aspects related to the absence of direct contact
between therapist and patient. Some examples of these comments are:
“impersonal, no direct eye contact”, “little emotion possible”, “the person-
al relationship with the therapist is lost, this is only possible via face-to-
face”, “lack of personal contact between patient and caregiver”, “does
not adequately address comorbidity/crisis/suicide risk”.4.5. Expectance of treatments
Stakeholders' expectations regarding future integration of internet-
based treatments into conventional practices, in terms of incentives
and barriers, are reported in Table 6. According to all stakeholder groups
themost important reason for the implementation of ICBT into existing
care services was the reduced cost of treatment (33%). More rapid pa-
tient access to treatment was ranked the secondmost important incen-
tive among all stakeholder groups, with the exception of technology
businesses. Among all respondents the most important barrier forTable 2
Sample distribution, country and stakeholder level.
Country × stakeholder N, (%) Total sample
(N = 175)
Care provider
(N = 88)
Research In
(N = 26)
Total sample 175 (100) 88 (50.3) 26 (14.9)
France 7 (4.0) 5 –
Germany 58 (33.1) 26 2
Netherland 17 (9.7) 10 5
Poland 29 (16.6) 18 6
Spain 22 (12.6) 8 7
Sweden 24 (13.7) 13 1
Switzerland 13 (7.4) 7 3
United Kingdom 5 (2.9) 1 2implementation was the perception that their current care system
was not ready for service delivery of ICBT (21%). On the subgroup
level the responses differed, with stakeholder groups reporting limited
internet access/literacy (service-funders), lack of clinical effectiveness
(patient/service-users), and negative attitudes from patients and pro-
fessionals (government bodies) as themain barriers to implementation.
There were 23 comments on barriers. Caregivers provided most com-
ments (n = 15) and most frequently highlighted the negative aspects
of therapeutic alliance, clinical effect and patient commitment, and of
implementation aspects (cost and budgeting, training of staff). Com-
ments from the other groups were on the same topics and also
highlighted potential fear of competition among care giving professions
and barriers in infrastructure (internet access).
4.6. Factors associated to stakeholder attitudes
Stakeholders from frontrunner countries (Netherlands, Sweden and
United Kingdom) were found to self-report higher knowledge of ICBT
(M = 3.4, SD = 1.3) compared to stakeholders in other countries
(M=2.5, SD=1.7) (χ2, p ≤ 0.05). Organisations that reported discussing
digital treatments recommended ICBT and BT to a higher degree com-
pared to other organisations (χ2, p b 0.05–0.001), with the exception of
ICBT for severe depression. German responders represented 33% of the
total sample and post-hoc tests (χ2, p b 0.05) showed that these organisa-
tions indicated signiﬁcant lower knowledge of ICBT (M=2.2), and lower
activity on digital treatments (45%) compared to the rest of the sample
(73%). No signiﬁcant differences were reported on the other topics.
5. Discussion
5.1. Summary of ﬁndings
This survey is the ﬁrst to report mental health stakeholder's attitudes
towards internet-based treatment (ICBT) and blended treatment (BT) for
adult depressiononEuropean level. The results showed that stakeholder'sst. Governing body
(N = 27)
Patient org.
(N = 14)
Tech. provider
(N = 9)
Funder
(N = 11)
27 (15.4) 14 (8.0) 9 (5.1) 11 (6.3)
– 2 – –
19 5 1 5
– – 1 1
– 4 1 –
2 – 3 2
4 1 3 2
2 – – 1
– 2 – –
Table 3
Stakeholders self-reported knowledge of internet-based treatment (ICBT) for adult depression, European level.
Knowledgea
(m, SD)
Total sample
(N = 168)
Care providers
(N = 88)
Research Inst.
(N = 26)
Governing body
(N = 21)
Patient org.
(N = 14)
Tech. providers
(N = 9)
Funders
(N = 10)
Reported knowledgeb 2.7 (1.6) 2.6 (1.6) 2.9 (1.4) 1.8 (1.9) 2.6 (1.4) 4.3 (1.0) 3.3 (1.3)
Rated on a six-point scale: 0 = no knowledge at all, to 5 = very good knowledge.
a Original wording: “To what extent does your organisation have knowledge about internet-based psychotherapy (referred to as online therapy and web-based treatment) as a
treatment tool for adult depression?”.
b Signiﬁcant differences among groups: p b 0.01. Respondents that indicated “does not apply” (total N = 7) were excluded.
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majority (64%) discussed ICBT for depression or were in some other way
engaged with the topic. In terms of implementing ICBT into regular care
services, stakeholders considered improved cost-efﬁciency to be the
main advantage, and low feasibility of delivery within present care sys-
tems to be the primary barrier. ICBT andBT had higher level of acceptance
for milder forms of depression. A comparison of ICBT and BT showed that
the acceptancewas considerably higher for BT, and this resultwas consis-
tent for all stakeholder subgroups. On group level, it was also found that
government bodies indicated lesser knowledge and held more conserva-
tive attitudes towards ICBT compared to other stakeholders. Organisa-
tions from countries considered frontrunners in e-mental health
reported greater knowledge and more positive attitudes towards digital
treatments compared to other organisations.
5.2. Perceived advantages and barriers
Stakeholders' opinion of cost-effectiveness being the primary advan-
tage of ICBT is in line with advantages argued in scientiﬁc reports
(Andersson, 2014). This reﬂects the views of a range of stakeholders
in countries that are diverse in terms of care infrastructure and e-health.
Consequently, we may infer that there exists a broad agreement on the
rationale for delivery of digital treatments for depression. However,
many stakeholders also indicated that they did not expect current care
systems to be ready for an integration of ICBT—stakeholders expected
this to be primary barrier for implementation. On stakeholder group
level the results further revealed that expectations in some cases
seemed to be based on assumptions about other stakeholder groups.
For example, government bodies expected negative attitudes from pa-
tients and professionals to be a primary barrier for implementation.
This belief was supported by patient and caregiver reports of concerns
about limitations of internet use, ethical issues, and clinical effectiveness
of digital treatments. Moreover, the barriers considered by caregivers
and patient organisations are aspects that are to some extent the re-
sponsibility of researchers and technology providers. The results show
that there is a variation in perceived barriers between stakeholders, in-
dicating the need for future multi-stakeholder consultations on digital
treatments to avoid biased ﬁndings.
5.3. Result on acceptance of digital treatments
The acceptance of digital treatments varied with the severity of de-
pression. ICBT was perceived as suitable for mild depression only, evenTable 4
Stakeholders report on whether their organisation discuss or proclaim internet-based treatme
Activitya (%) Total
(N = 159)
Care providers
(N = 82)
Research Inst.
(N = 22)
Activity
Yesb (full or partial)⁎ 64.2 64.6 90.9
No 20.8 24.4 4.5
Does not apply 15.1 11.0 4.5
Single-choice question.
⁎ Signiﬁcant differences among groups: p b 0.001.
a Original wording: “Is your organisation discussing and/or proclaiming internet-based psyc
b The original alternatives “yes” and “partly” have been merged into one category.though ICBT is well researched and has repeatedly shown to be an effec-
tive treatment for adult depression, even for severe stages (Meyer et al.,
2015; Richards and Richardson, 2012). The signiﬁcantly higher accep-
tance for BT (a relatively novel treatment approach yet to be evaluated
in clinical trials) indicates that the scepticism presented for ICBT may
not only be explained by lack of knowledge about both the ICBT concept
or the evidence-base for the approach. The reasons for the reported differ-
ence in the level of acceptance was not directly assessed in this survey,
however a review of free text comments made about ICBT throughout
the survey revealed opinions that are similar to those previously reported
bymental health professionals and students (Mitchell and Gordon, 2007;
Stallard et al., 2010). ICBT is perceived as ‘impersonal’, and concerns in
this survey were in most cases associated with the elimination of face-
to-face interaction between patient and therapist. The results indicate
that attitudes do not seem to change in pace with new digital develop-
ments, considering the increased everyday use of technology that is also
being widely applied in mental health settings (Patrick et al., 2016). The
comparison of ICBT and BT was made for the ﬁrst time in the E-COM-
PARED survey and the results are interesting. The readily acceptance for
BT raise the questions as to what extent do stakeholders attribute treat-
ment outcomes to objectives achieved during face to face meetings, and
if blended treatment approaches may present a middle path for digital
treatments that can be considered more acceptable. Of interest is also to
explore if the attitudes for ICBT compared to BT are similar for conditions
that are not associatedwith suicide risks (for example anxiety disorders).
5.4. Results on stakeholder group and country level
Explorations on sub-group level revealed that government bodies
self-reported signiﬁcantly less knowledge and activity on ICBT compared
to other stakeholder groups. Given that these organisations hold high-
level inﬂuence and several of the countries targeted in the survey have re-
cently revised their mental health policies to be more inclusive of e-
health, the results were somewhat unexpected. Possibly the responses
from this group reﬂect that for many institutional bodies it is a prerequi-
site that the effect of ICBT has been proven in real world settings before
moving forward with dissemination initiatives. Future dissemination ac-
tivitiesmay consider directing further attention to this stakeholder group.
Patient organisations showed the least level of acceptance for ICBT as
treatment for depression, andwere concerned about the clinical and eth-
ical aspects of treatment. Thisﬁnding goes against previous reports of pa-
tients being more positive towards ICBT than clinicians (Andersson,
2014). A recent study, which explored patients' and clinicians'nt (ICBT), European level.
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 8)
Funders
(N = 10)
33.3 61.5 100 50.0
29.2 23.1 0 20.0
37.5 15.4 0 30.0
hotherapy as a future enhancement in mental health care?”.
Table 5
Stakeholders recommendation of digital treatments, European level.
Recommend (%) Total
(N = 159)
Care providers
(N = 82)
Research Inst.
(N = 22)
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 8)
Funders
(N = 10)
Standalone Internet-based treatmenta
Mild depression* 46.5 39.0 72.7 33.3 38.5 75.0 70.0
Moderate depression* 15.7 13.4 31.8 12.5 0 37.5 10.0
Severe depression** 1.9 2.4 0 0 0 12.5 0
Blended treatmentb
Mild depression 69.8 72.0 81.8 45.8 76.9 75.0 70.0
Moderate depression** 57.2 54.9 72.7 29.2 76.9 70.0 70.0
Severe depression** 27.0 22.0 40.9 8.3 38.5 50.0 50.0
Single-choice question: “yes”, “no”, “does not apply”.
Signiﬁcant differences among groups: * = p b 0.05, ** = p b 0.01.
a Original wording: “Do you/Would your organisation recommend stand-alone treatment full psychotherapy program for computer/tablet/smartphone, with online educational ma-
terial and communication with health care professional?”.
b Original wording: “Does/Would your organisation recommend traditional face-to-face treatmentwith the addition of a web-based platform and digital tools for support, with the aim
of reducing the number of face-to-face sessions while maintaining the same treatment quality?”.
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patients were more accepting than clinicians (van der Vaart et al.,
2014). The reason for the ﬁndings of the E-COMPARED survey is un-
known, but possible explanationsmay be that themajority of patient or-
ganisations came from Germany and Poland (where ICBT is not widely
known) or that patient representatives and not actual patients partici-
pated in this survey.
Stakeholders from countries with more integrated e-mental health
services (Netherlands, Sweden, United Kingdom) had more knowledge
of ICBT and were more positive towards ICBT. In these countries, cogni-
tive behaviour therapy is the dominant orientation of psychotherapy,
and it is possible that this might interplay with participants' attitudes.
In contrast, for example France has a strong tradition of psychodynamic
therapies, and French stakeholders rated the relevance and advantage
of ICBT as low (result not included in this paper).
6. Strengths and limitations
One of themain strengths of the surveywas the purposive sample of
stakeholders representing the current status in Europe in terms of careTable 6
Incentive/barrier for an implementation of standalone internet-based treatment (ICBT) into ca
Incentive/barrier (%) Total
(N = 155)
Care providers
(N = 80)
Researc
(N = 2
Incentivea
Reduced cost of treatment 32.9 27.5 47.6
Patient access to treatment 21.9 25.0 14.3
Patient empowerment 7.1 10.0 0
Reduced treatment gap 6.5 6.3 14.3
Clinical effect corresponds to TAUb 5.8 7.5 9.5
Patient convenience 5.2 8.8 0
None 3.9 3.8 0
Other 2.6 0 4.8
Patient adherence 0.6 0 4.8
Do not know/does not apply 13.5 11.3 4.8
Barriera
Health care system not ready 20.6 22.5 23.8
Clinical effect inferior to TAUb 14.8 16.3 19.0
Professional/patient attitude (neg) 12.3 8.8 14.3
Limited internet literacy & access 12.2 11.3 14.3
Other 9.0 10.0 9.5
Limited online safety 8.4 10.0 9.5
Not ethical 3.9 2.5 0
Not time/cost effective 3.9 5.0 0
Cultural barriers 2.6 3.8 4.8
None 0.6 1.3 0
Do not know/does not apply 11.6 8.8 4.8
a Original wording: “What does your organisation expect to be themost important incentive
depression in your country's health care system?”.
b TAU= treatment as usual. Bold prints identify the most frequently reported answer.infrastructure and e-health integration. The surveymanaged to recruit a
large number of organisations that represented all targeted stakeholder
categories and countries. A high proportion of participants completed
the full survey (82%). Several limitations of the survey need to be con-
sidered when interpreting the results. The sample can be considered a
convenience sample (introducing recruitment and response biases),
and the response-rate variedwidely between countries and stakeholder
groups. There was no higher limit of participants in recruitment guide-
lines, which for example is reﬂected in the high proportion of German
responders. Post-hoc test showed that German responders differed
fromothers on the topic of knowledge and activity. Alongwith the over-
all limitations in sampling and distribution this may affect the certainty
of obtained results. Moreover, many organisations did not accept the
invitation (response-rate 23%) and no information on reasons for
non-responding was collected. It should also be mentioned that al-
though efforts were made to ensure that survey questions were
interpreted the same way across countries and stakeholder catego-
ries, and that respondents were repeatedly instructed to answer on
behalf of their organisation, there were no formal procedures to con-
trol that this was achieved.re systems, European level.
h Inst.
1)
Governing body
(N = 24)
Patient org.
(N = 13)
Tech. providers
(N = 7)
Funders
(N = 10)
33.3 38.5 42.9 30.0
20.8 30.8 0 20.0
4.2 7.7 14.3 0
4.2 0 14.3 0
4.2 0 0 0
0 7.7 0 0
4.2 7.7 0 10.0
0 0 14.3 20.0
0 0 0 0
29.2 7.7 14.3 20.0
12.5 23.1 28.6 10.0
8.3 30.8 0 0
20.8 7.7 14.3 20.0
4.2 7.7 14.3 40.0
8.3 0 14.3 10.0
8.3 7.7 0 0
4.2 23.1 0 0
4.2 0 0 0
0 0 0 0
0 0 0 0
29.2 0 28.6 20.0
/barrier for integrating internet-based psychotherapy as a stand-alone treatment for adult
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The relevance of e-mental health in relation to the treatment gap is stated in scientiﬁc and legislative reports. It is therefore necessary to
assess the views of stakeholders that are involved/affected by mental health care provisions. The E-COMPARED survey presents its ﬁndings
on European stakeholders' opinions (valid for diverse European settings) about digital treatments in terms of their knowledge, acceptance
and expectations. The results obtained on knowledge and activity are in line with what we expected. These ﬁndings highlight the need to dis-
seminate not only results of clinical and cost effectiveness but also to share best practices and clearly communicate for whom, when and how
digital treatments might be applied. The results on acceptance for different treatment approaches (ICBT and BT) provide new information on
what may inﬂuence stakeholders' attitudes towards technology in treatment. The ﬁndings on blended treatment are interesting, and future
research can further investigate whether a gradual integration of technology into clinical practice (i.e., blended treatment) might ﬁt with
the attitudes and expectations of mental healthcare stakeholders. The results of the E-COMPARED survey can serve as the foundation for future
stakeholder dissemination activities in terms of what information should be provided, and what topics may be perceived as relevant by differ-
ent stakeholder categories.
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